Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical hallmark of FCS is pancreatitis associated with marked chylomicronemia and triglyceridemia. It is important that gastroenterologists recognize the signs and symptoms to properly evaluate, as well as manage, patients with FCS. In this activity, a gastroenterologist will review the diagnosis, assessment, management, ongoing challenges, and future therapeutic options for patients with ...
Slack Inc.

Age Matters: Implementing New Recommendations for HPV Immunization in Adolescents

Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various types of cancer. An estimated 79 million Americans are infected with some type of HPV, and approximately 50% of new infections occur before the age of 24. Despite the availability of safe and effective vaccines, HPV vaccination coverage remains low. There are a number of reasons why the vaccination rates are low, including lack of knowledge about HPV and di...
Slack Inc.

Preventing Medical Errors for Clinical Health Professionals

This educational monograph addresses the identification, reporting, monitoring and reduction of medical error. It is intended to make participants aware of the magnitude of the problem, of the many-leveled activities needed to resolve it, and the importance of each person’s role in the national effort to reduce medical errors.
Slack Inc.

Domestic Violence 3 Hour: Focus on Child Abuse

This course focuses on child maltreatment, abuse and neglect within the larger context of domestic or family violence. The dynamics of domestic violence are presented using Pence and Paymer’s power and control wheel as a guiding explanatory model (1986). Common forms of child maltreatment, abuse and neglect are described and categorized with physical and behavioral symptoms. Opportunities for preventive education and support are described. Health care professionals’ responsibilities and ma...
Slack Inc.

Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management

Approximately 150 million people worldwide have diabetes mellitus and this number is expected to double by 2025. Numerous therapeutic advances have emerged, including oral and injectable pharmacologics as well as novel insulin analogs. However, many patients continue to experience poor glycemic control. This Rapid Response activity will highlight the latest evidence from the 2017 American Association of Clinical Endocrinologists (AACE) 26th Annual Scientific & Clinical Congress on the efficacy...
Slack Inc.

Focus on Female and Male Aesthetics

Facial Aesthetics New York 2016 was an excellent opportunity to gain experienced perspective from a nationally-recognized and multidisciplinary faculty who collectively represent the areas of dermatology, facial plastic surgery, plastic surgery and oculoplastics. It offered a comprehensive approach to facial aesthetics – from science to technique to practice management. Program topics include: aging, female vs. male, basic to advanced and fillers, complications and practice management. This ...
Slack Inc.

Facial Aging

Facial Aesthetics New York 2016 was an excellent opportunity to gain experienced perspective from a nationally-recognized and multidisciplinary faculty who collectively represent the areas of dermatology, facial plastic surgery, plastic surgery and oculoplastics. It offered a comprehensive approach to facial aesthetics – from science to technique to practice management. Program topics include: aging, female vs. male, basic to advanced and fillers, complications and practice management. This ...
Slack Inc.

Ace the Case: A 29-year-old Woman with Psoriasis Vulgaris

This “Ace the Case” study will discuss the assessment and treatment of a 29-year-old woman with Psoriasis Vulgaris. Accurately assess the appropriate treatment option(s) for this patient for CME credits.
Slack Inc.

Eye on an Enigma: New Mechanisms of Action in the Medical Management of Glaucoma

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to stop or slow disease progression. Current glaucoma medications achieve this almost exclusively through reduction of intraocular pressure (IOP). Unfortunately, even with appropriate use of currently available medications, many people with glaucoma will still experience vision loss. Intraocular pressure is the only known modifiable risk factor for patients with glaucoma, so impr...
Slack Inc.

Inflamed and Untamed: Managing the Progression of Diabetic Eye Disease

Diabetic retinopathy (DR) is a major cause of blindness, with an estimated 4.2 million people over the age of 40 affected by this condition within the United States. Loss of vision is most frequently due to diabetic macular edema (DME), a consequence of DR, but it can also be a direct result of DR. Inflammation plays an important role in the pathogenesis of DME, and recent advances in the understanding of the underlying pathophysiology of the disease have led to the development of therapies fo...
Slack Inc.

Treating Advanced Dry Age-related Macular Degeneration and Geographic Atrophy: Here and Now

Age-related macular degeneration (AMD) is a deterioration or breakdown of the eye's macula. At present, pharmacotherapy is available only for late neovascular AMD. The prospect of effective therapies in the near future, together with an increasing incidence of AMD in an aging population, has led to increased interest in early, accurate diagnosis and classification of AMD, as well as medications to effectively treat it. This educational program will address imaging techniques and technology, ev...
Slack Inc.

Dry Eye and Systemic Disease: Cause, Effect, and Solutions

Dry eye disease (DED) is a condition of the ocular surface in which multiple factors are responsible for the disturbance of the stability of tear film, leading to changes in vision and symptoms that significantly disrupt the quality of life of many individuals in the United States and elsewhere. There is a well-known association of several systemic diseases associated with dry-eye syndrome, among them Sjögren's syndrome, rheumatoid arthritis, scleroderma and systemic lupus erythematosus. This...
Slack Inc.

The University of Chicago Digestive Diseases Review: University of Chicago Medicine & Biological Sciences Specialty Review (SA-CME)

Studying the University of Chicago Digestive Diseases Review will help you to better: • Keep up with the latest advancements regarding the biology and treatment of patients with digestive diseases • Apply new knowledge in GI, hematology, and nutrition with this review in gastroenterology • Integrate current guidelines into daily practice when preventing and managing digestive diseases
CMEInfo

Topics in Risk Management 5th Edition

Studying Topics in Risk Management 6th Edition will give you: • An understanding of how economist experts for the defense and for the plaintiff approach and calculate the compensatory damages awarded by juries in medical malpractice cases. • Ten practical rules and numerous other tips to help defendant doctors effectively prepare for a deposition, which is their best opportunity to influence the outcome of a malpractice case. • An introduction to intermediation, a formalized process t...
CMEInfo

Gastroenterology and Hepatology Board Review: Oakstone Board Review

At the conclusion of the Gastroenterology and Hepatology Board Review, you will be able to: • Apply an evidence-based approach to the diagnosis and treatment of gastrointestinal and liver disorders • Discuss the difference between gastroesophageal reflux disease and Barrett's esophagus • Differentiate among motility disorders: gastroparesis, functional dyspepsia, ileus • Assess therapy options for C. Difficile colitis • Summarize screening procedures and diagnostic criteria for ...
CMEInfo

Focus on Dermal Fillers–Basic and Advanced Techniques

Facial Aesthetics New York 2016 was an excellent opportunity to gain experienced perspective from a nationally-recognized and multidisciplinary faculty who collectively represent the areas of dermatology, facial plastic surgery, plastic surgery and oculoplastics. It offered a comprehensive approach to facial aesthetics – from science to technique to practice management. Program topics include: aging, female vs. male, basic to advanced and fillers, complications and practice management. This ...
Slack Inc.

Focus on Practice Management: Incorporating into Your Practice

Facial Aesthetics New York 2016 was an excellent opportunity to gain experienced perspective from a nationally-recognized and multidisciplinary faculty who collectively represent the areas of dermatology, facial plastic surgery, plastic surgery and oculoplastics. It offered a comprehensive approach to facial aesthetics – from science to technique to practice management. Program topics include: aging, female vs. male, basic to advanced and fillers, complications and practice management. This ...
Slack Inc.

Updates in Psoriasis Treatment: New Data from Vienna

Plaque psoriasis is a debilitating, noncurable autoimmune disorder, having a significant impact on quality of life, associated with depression, anxiety, social isolation, unemployment, and suicide. Various therapies, such as topical formulations and phototherapy, are currently available. The latest breakthroughs in understanding the immunopathology underlying plaque psoriasis include the identification of interleukins (IL-17, IL-22, and IL-23), which drive the chronic inflammatory nature of th...
Slack Inc.

Ace the Case: 72 Year-old Woman with Left Side Numbness and Speech Problems

This “Ace the Case” study will discuss the treatment of a 72-year-old woman presenting with left side numbness and speech problems. Accurately assess the appropriate treatment option(s) for this patient for CME credits.
Slack Inc.

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

With each passing year we gain new insight and understanding around the clinical utilization of lipid-lowering therapeutic agents. Our historical experience with older agents can often inform our knowledge and interpretation of how we view newly available options and those in development. How does our prior experience with statins and LDL-C lowering help us to better utilize and contextualize the newest classes of specialized high-intensity therapies? When do we consider off-label drug use ...
Slack Inc.

Practical Lipidology® Volume 4, Number 1: Focus on LDL Reduction and PCSK9 Inhibition

A preponderance of data shows that low-density lipoprotein cholesterol (LDL-C) plays a causal role in atherosclerotic cardiovascular disease. Despite highly effective statin therapy, some patients fail to achieve desired LDL-C reductions, and therefore remain at high risk of a cardiovascular event. For these patients, the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors represent a promising new strategy. In this activity, expert faculty will review the latest evidence from rec...
Slack Inc.

Integrating New Options Into Guideline-Directed Management of Heart Failure with Reduced Ejection Fraction

Heart failure (HF) is a chronic condition that requires long-term commitment on the part of the patient in adhering to an often-complex therapeutic and monitoring regimen, including lifestyle modifications and pharmacotherapy, and on the part of the clinician in maintaining knowledge to prescribe the most advantageous interventions. Although guidelines are widely available for the treatment of HF, gaps exist between these guidelines and actual care. Additionally, newly available remote monitor...
Slack Inc.

Collaborative Care Strategies for Reducing Hospital Readmissions in Patients with Heart Failure with Reduced Ejection Fraction

Heart failure (HF) is a chronic condition that requires long-term commitment on the part of the patient in adhering to an often-complex therapeutic and monitoring regimen, including lifestyle modifications and pharmacotherapy, and on the part of the clinician in maintaining knowledge of the most current therapies and devices to maximize efficacy, minimize side effects, improve monitoring, and reduce hospital readmissions. New treatments and technology have shown promise in improving outcomes i...
Slack Inc.

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and recurrent episodes of acute pancreatitis. Due to its rarity and nonspecific signs and symptoms, FCS is often hard to diagnose. Currently, there is a lack of effective treatments for patients with FCS, although several agents in development show promise. Cardiologists play a crucial role in the diagnosis and ongoing care of patients with FCS; thus, it is critical to improve knowledge ...
Slack Inc.

The Future of the Lipid Panel: An NLA Expert Discussion

Past-President of the National Lipid Association and Editor-in-Chief of the Journal of Clinical Lipidology, Dr. W. Virgil Brown is joined by Drs. Yehuda Handelsman, Pamela Morris, and Seth Martin to discuss new issues in lipoprotein management, including assessment of treatment targets, documenting and using new targets of treatment and the setting of goals-setting for these lipoprotein targets. This included the use of clinical trial data, and the feasibility of applying new laboratory measur...
Slack Inc.

Cytokines, Janus Kinase Inhibitors, and Small-Molecule Therapies, Oh My!: New Inroads Into Rheumatoid Arthritis Management

Although the introduction of biologic agents has transformed treatment paradigms for rheumatoid arthritis (RA), a considerable proportion of patients do not respond sufficiently to these therapies. A potential new therapeutic alternative for these patients is small-molecule inhibitors, which offer targeted inhibition of intracellular pathways that can be achieved via oral administration. To realize the benefits of small-molecule inhibitor therapy, it is essential for clinicians to know how the...
University of Chicago Pritzker School of Medicine and RedMedEd

Strategies for Preventing HIV-related Cardiovascular Disease

This text-based interview is the first of a four-part series. Dr. Chris Longenecker and Dr. Turner Overton address CVD risks in HIV-infected individuals, such as contributing factors for CVD (inflammation and immune activation), the impact of antiretroviral drug treatment (ART), risk factor modification, and ongoing clinical trials. HIV-infected individuals have an increased risk of CVD. Research has identified characteristics of HIV infection itself that influence CVD risks, yet their pre...
ACHL

The Immunosuppression Balancing Act: Preserving Long-Term Allograft Function for Optimal Patient Outcomes

The current goal of transplant medicine and immunology is to develop strategies to extend the life and functionality of every allograft. Outcomes of renal and liver transplantation have improved; yet, allograft loss remains a substantial problem associated with increased morbidity, mortality, and costs. Education to transplant clinicians about evaluating all aspects of post-transplant care, including regular monitoring, can lead to a reduction in allograft dysfunction or loss. In addition, ...
CME Outfitters, LLC

Integrated Care Strategies to Address the Impact of Residual Symptoms on Functional Outcomes in MDD

Depression is one of the leading causes of disability worldwide. It affects individuals, families, businesses, and society and is common in patients seeking care in the primary care setting. Approximately 55% of patients will respond to treatment with the initial antidepressant. Yet, even in those patients who respond to treatment and achieve remission, residual symptoms can significantly inhibit functionality and increase the risk of relapse and recurrence. Despite these challenges, MDD ca...
CME Outfitters, LLC

Deep Remission, Top-Down Treatment Strategies and Real-World Data in Patients with UC: An Interactive and Innovative Case Series

Ulcerative colitis (UC) is an inflammatory bowel disease with a progressive course characterized by exacerbations and remissions. Traditionally, the goals of therapy for UC have entailed resolution of clinical symptoms such as rectal bleeding, bloody diarrhea, abdominal cramps, pain, and fatigue. However, treatment goals for UC have evolved to a treat-to-target strategy with targets such as mucosal/endoscopic healing, histologic healing, or deep remission (i.e., clinical, biochemical, and endo...
CME Outfitters, LLC

Treating the Full Spectrum of Narcolepsy: Improving Nighttime Symptoms to Enhance Daytime Quality of Life: A Moderated Discussion with the Experts and Q&A

Patients with narcolepsy often face a long journey on their path to diagnosis and effective treatment. Combating the negative impact of narcolepsy on the lives of those affected requires that both the general public and the medical community increase their awareness of the symptoms of narcolepsy, in particular, the most common presenting symptoms: cataplexy and excessive daytime sleepiness. Improved recognition of both symptoms and objective measures of narcolepsy can shorten the burdensom...
CME Outfitters, LLC

From Symptom Recognition to Narcolepsy Diagnosis: Shortening the Diagnostic Journey: A Moderated Discussion with the Experts and Q&A

Patients with narcolepsy often face a long journey on their path to diagnosis and effective treatment. Combating the negative impact of narcolepsy on the lives of those affected requires that both the general public and the medical community increase their awareness of the symptoms of narcolepsy, in particular, the most common presenting symptoms: cataplexy and excessive daytime sleepiness. Improved recognition of both symptoms and objective measures of narcolepsy can shorten the burdensom...
CME Outfitters, LLC

Recognizing the Symptoms of Narcolepsy: Screening Your Sleepy Patient for Cataplexy: A Moderated Discussion with the Experts and Q&A

Patients with narcolepsy often face a long journey on their path to diagnosis and effective treatment. Combating the negative impact of narcolepsy on the lives of those affected requires that both the general public and the medical community increase their awareness of the symptoms of narcolepsy, in particular, the most common presenting symptoms: cataplexy and excessive daytime sleepiness. Improved recognition of both symptoms and objective measures of narcolepsy can shorten the burdensom...
CME Outfitters, LLC

Challenges in Patient Safety in Psychiatry

Patients with mental illness are at higher risk for adverse events including suicide, lack of medication adherence, and less likely to seek help during relapse. As pressure to discharge increases in addition to treatment plans, patients with mental illness must also have a safety plan beyond the length of hospitalization that makes the patient an equal participant and involves their entire care team, including family members. In this CME Outfitters Snack, expert faculty will discuss safety...
CME Outfitters, LLC

Advancing the Treatment of Focal Seizures in the Intensive Care Setting: A Multidisciplinary Team Approach

Seizures are a common occurrence in the intensive care setting with incidence estimates ranging from 3.3% to 34%. Encountering seizures in the intensive care unit (ICU) is frightening to patients and caregivers. Discharge orders that include new medication and possibly a new diagnosis—in addition to other orders or instructions can be daunting and confusing. Clinicians need strategies focused on the needs of the patients for optimal outcomes. Seizures occurring in the ICU require timely ...
CME Outfitters, LLC

Deep Remission, Mucosal Healing, and Top-Down Treatment Strategies in Ulcerative Colitis: An Infographic Journey

Ulcerative colitis (UC) is an inflammatory bowel disease with a progressive course characterized by exacerbations and remissions. Traditionally, the goals of therapy for UC have entailed resolution of clinical symptoms such as rectal bleeding, bloody diarrhea, abdominal cramps, pain, and fatigue. However, treatment goals for UC have evolved to a treat-to-target strategy with targets such as mucosal/endoscopic healing, histologic healing, or deep remission (i.e., clinical, biochemical, and endo...
CME Outfitters, LLC

Bringing Health Care Providers Together to Diagnose and Treat Idiopathic Pulmonary Fibrosis: A Patient Simulation

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States. Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis...
CME Outfitters, LLC

Problem Based Learning in HBV: A Patient Simulation for Improving Treatment Decisions and Long-Term Care

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States despite the availability of screening guidelines and prophylactic vaccines. Chronic HBV infection causes severe complications, including cirrhosis and hepatocellular carcinoma in 20% - 30% of patients. As a result, HBV infection is the most common reason for liver transplantation. While recommendations exist, primary care providers are not adequately screening at-risk patients for HBV infect...
CME Outfitters, LLC

Treating to Target in Patients with Gout and Chronic Kidney Disease: A Patient Simulation

Gout is the most common form of inflammatory arthritis in the United States. Hyperuricemia/gout in patients with CKD constitutes a significant burden for patients and society. Patients who are not managed adequately experience painful gout attacks, loss of function and productivity, and may develop long-term complications. The economic burden is also increased from patient utilization of prescription medication use, emergency room visits, and hospitalizations from gout or its serious complicat...
CME Outfitters, LLC

Selecting Appropriate Treatment for Patients With IPF: Applying Guidelines and Clinical Evidence

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States. Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis...
CME Outfitters, LLC

Working Together to Diagnose IPF: A Multidisciplinary Approach

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States. Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis...
CME Outfitters, LLC

Working Together to Diagnose IPF: Identifying the Signs and Symptoms

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States. Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis...
CME Outfitters, LLC

Taking Action Against Chronic Hepatitis B Virus Infection: Determining Which Patients to Treat or Monitor

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States. Only 33% of the estimated one million Americans living with HBV are aware that they are infected, placing them at risk for spreading the infection to others, and developing liver failure, cirrhosis, or hepatocellular carcinoma (HCC). As a result, HBV infection is the most common reason for liver transplantation. Primary care providers are not adequately screening at-risk patients for HBV in...
CME Outfitters, LLC

Taking Action Against Chronic Hepatitis B Virus Infection: Counseling Patients on Serological Results

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States. Only 33% of the estimated one million Americans living with HBV are aware that they are infected, placing them at risk for spreading the infection to others, and developing liver failure, cirrhosis, or hepatocellular carcinoma (HCC). As a result, HBV infection is the most common reason for liver transplantation. Primary care providers are not adequately screening at-risk patients for HBV in...
CME Outfitters, LLC

Your Test is Abnormal; Patient-Centered Care for Difficult Conversations

Conversations about abnormal test results in general and positive HPV tests in particular are challenging. Research shows that patients often come away from these discussions with misinformation, feeling stigmatized, fearful, and likely to be non-adherent with follow-up plans. The goal is for patients to come away from these conversations without unnecessary anxiety and with the accurate information they need to make informed decisions and follow through with next-steps. What are the best coun...
ASCCP, The Society of Lower Genital Tract Disorders

Clinical Endocrinology 2018

Clinical Strategies and Comprehensive Updates for State-of-the-Art Endocrine Care For nearly 50 years, renowned experts in endocrinology at Harvard Medical School and Massachusetts General Hospital have delivered Clinical Endocrinology—the acclaimed annual update of current endocrine diagnostic and management strategies. If you provide care to patients with endocrine disorders, this course will be invaluable to your medical decision making and patient care. ENDOCRINOLOGISTS, INTERNISTS, FA...
Harvard Medical School Global and Continuing Education

Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS

Upon completion of this activity, participants should be better able to: •Integrate new and emerging information on the pathophysiology of MS, including modifiable risk factors, in the development of individualized treatment plans •Access reliable and evidence-based resources in order to stay current with advances in the management of MS
The France Foundation

The Gut Microbiota in MS

Upon completion of this activity, participants should be better able to: •Integrate new and emerging information on the pathophysiology of MS, including modifiable risk factors, in the development of individualized treatment plans •Access reliable and evidence-based resources in order to stay current with advances in the management of MS
The France Foundation

Early MS: Induction Therapy and Escalation Strategies

Upon completion of this activity, participants should be better able to: •Analyze data from clinical trials of disease modifying therapies to inform personalized treatment and monitoring of outcomes for patients with MS •Access reliable and evidence-based resources in order to stay current with advances in the management of MS
The France Foundation

Comorbidities and Selection of DMTs

Upon completion of this activity, participants should be better able to: •Analyze data from clinical trials of disease modifying therapies to inform personalized treatment and monitoring of outcomes for patients with MS •Access reliable and evidence-based resources in order to stay current with advances in the management of MS
The France Foundation

YouTube Google+ Pinterest Twitter LinkedIn Facebook SlideShare
RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.